[go: up one dir, main page]

WO2001020337A8 - Genetic testing for periodontitis based on cathepsin c - Google Patents

Genetic testing for periodontitis based on cathepsin c

Info

Publication number
WO2001020337A8
WO2001020337A8 PCT/GB2000/003512 GB0003512W WO0120337A8 WO 2001020337 A8 WO2001020337 A8 WO 2001020337A8 GB 0003512 W GB0003512 W GB 0003512W WO 0120337 A8 WO0120337 A8 WO 0120337A8
Authority
WO
WIPO (PCT)
Prior art keywords
cathepsin
periodontitis
genetic testing
periodontitis based
assaying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2000/003512
Other languages
French (fr)
Other versions
WO2001020337A1 (en
Inventor
Nalin Thakker
Michael Dixon
Jacqueline James
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Manchester
Original Assignee
Victoria University of Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Victoria University of Manchester filed Critical Victoria University of Manchester
Priority to AU73004/00A priority Critical patent/AU7300400A/en
Publication of WO2001020337A1 publication Critical patent/WO2001020337A1/en
Publication of WO2001020337A8 publication Critical patent/WO2001020337A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/488—Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to a method for diagnosing or detecting a predisposition to periodontitis comprising assaying a bodily sample in vitro directly or indirectly for a reduced level of cathepsin, by assaying at either a protein or genetic level. Also provided is a method of treatment of periodontitis and kits for performing the assay.
PCT/GB2000/003512 1999-09-14 2000-09-13 GENETIC TESTING FOR PERIODONTITIS BASED ON CATHEPSIN c Ceased WO2001020337A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU73004/00A AU7300400A (en) 1999-09-14 2000-09-13 Genetic testing

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9921544.4A GB9921544D0 (en) 1999-09-14 1999-09-14 Genetic testing
GB9921544.4 1999-09-14

Publications (2)

Publication Number Publication Date
WO2001020337A1 WO2001020337A1 (en) 2001-03-22
WO2001020337A8 true WO2001020337A8 (en) 2001-06-07

Family

ID=10860777

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2000/003512 Ceased WO2001020337A1 (en) 1999-09-14 2000-09-13 GENETIC TESTING FOR PERIODONTITIS BASED ON CATHEPSIN c

Country Status (3)

Country Link
AU (1) AU7300400A (en)
GB (1) GB9921544D0 (en)
WO (1) WO2001020337A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017009214A1 (en) * 2015-07-10 2017-01-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Early and non invasive method for assessing a subject's risk of having a papillon-lefevre syndrome

Also Published As

Publication number Publication date
WO2001020337A1 (en) 2001-03-22
GB9921544D0 (en) 1999-11-17
AU7300400A (en) 2001-04-17

Similar Documents

Publication Publication Date Title
TWI256975B (en) Compositions containing a urea derivative dye for detecting an analyte and methods for using the same
WO2000004187A3 (en) Methods and kits for diagnosing and determination of the predisposition of diseases
WO2002077604A3 (en) Labeled cells for use as an internal functional control in rare cell detection assays
CA2448713A1 (en) Analytical instruments, biosensors and methods thereof
WO2002073204A3 (en) Cell-based detection and differentiation of disease states
CA2249638A1 (en) Kit and method for fluorescence based detection assay
WO2003043487A3 (en) Method of using a non-antibody protein to detect and measure an analyte
WO2004025251A3 (en) Cell-based detection and differentiation of disease states
AU1981597A (en) Assay and reagents for quantifying hbnp
CA2334935A1 (en) Screening for blood coagulation defects using metal ions
CA2112702A1 (en) Assay methods and compositions for detecting serum proteases, particularly activated protein c
CA2267155A1 (en) Detecting genetic predisposition to sight-threatening diabetic retinopathy
AU2849300A (en) Methods and assay kits for detecting mononuclear cell phenotype
WO2004000884A3 (en) Compositions and methods for apo-b48 and apo-b100 assay
IL146454A0 (en) METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY
WO2001073114A3 (en) Reagents and methods for detecting a reduced cofactor
WO1999057306A3 (en) Method for diagnosing a vascular condition
WO2003100006A3 (en) Method of improved prostate cancer detection
WO2000075363A3 (en) Enzymatic measurement of mycophenolic acid
CA2341263A1 (en) Enzyme inhibition immunoassay
WO2002016943A3 (en) Differential immunoassay
CA2407760A1 (en) Methods for diagnosis of low grade astrocytoma
WO2003089896A8 (en) Rapid assay, method and system for detecting biowarfare agents
WO2001020337A8 (en) Genetic testing for periodontitis based on cathepsin c
WO2003100079A3 (en) Method of analyzing proenzyme forms of prostate specific antigen in serum to improve prostate cancer detection

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page

Free format text: REVISED TITLE RECEIVED BY THE INTERNATIONAL BUREAU AFTER COMPLETION OF THE TECHNICAL PREPARATIONS FOR INTERNATIONAL PUBLICATION

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP